Skip to main content
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 3, Number 4, 2002

Book Reviews

Preface
pp. i-i(1)
Author: Costi, M.

Favourites:
ADD

Reviews

Hepatitis C Virus Proteins as Targets for Drug Development: The Role of Bioinformatics and Modelling
pp. 281-296(16)
Authors: Lahm, A.; Yagnik, A.; Tramontano, A.; Koch, U.

Favourites:
ADD

The Means to an End of Tumor Cell Resistance to Chemotherapeutic Drugs Targeting Thymidylate Synthase: Shoot the Messenger
pp. 297-309(13)
Authors: Berg, R.W.; Ferguson, P.J.; DeMoor, J.M.; Vincent, M.D.; Vincent, M.D.; Koropatnick, J.

Favourites:
ADD

Multidrug Resistance Phenotype Mediated by the P-Glycoprotein-Like Transporter in Leishmania: A Search for Reversal Agents
pp. 311-333(23)
Authors: Perez-Victoria, J.M.; Pietro, A.; Barron, D.; Ravelo, A.G.; Castanys, S.; Gamarro, F.

Favourites:
ADD

Streptogramin Antibiotics: Mode of Action and Resistance
pp. 335-344(10)
Authors: Johnston, N.J.; Mukhtar, T.A.; Wright, G.D.

Favourites:
ADD

Mutation and Evolution of Antibiotic Resistance: Antibiotics as Promoters of Antibiotic Resistance?
pp. 345-349(5)
Authors: Blazquez, J.; Oliver, A.; Gomez-Gomez, J-M.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content